Impact of Inflation Reduction Act on Drug Prices & Innovation
TL/DR -
The introduction of the Inflation Reduction Act (IRA) in 2023 allowed Medicare to negotiate drug prices directly, leading to price reductions for certain drugs and impacting revenues for biopharmaceutical companies. The Biden administration is actively working towards lowering healthcare costs, and under the IRA, negotiations will include…